Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload. [Phase 4]
Phase 4 trial by Novartis evaluated the efficacy and safety of deferasirox in patients with myelodysplastic syndrome, thalassemia, and trans…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Phase 3]
Phase 3 trial update for darbepoetin alfa in anemic low or intermediate-1 risk myelodysplastic syndrome patients; study completed with resul…
-
CLINICAL_TRIALS research · 2016-11-16Clinical Trial Update: MDS-CAN: A Prospective National MDS Clinical Database and Local Tissue Bank
A prospective national myelodysplastic syndrome clinical database and local tissue bank (MDS-CAN) is being established, sponsored by Sunnybr…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Erlotinib in Higher Risk Myelodysplastic Syndrome [Phase 1, Phase 2]
The Phase 1/2 clinical trial of erlotinib in higher-risk myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL [Phase 2]
Phase 2 study evaluating azacitidine with or without birinapant in patients with Myelodysplastic syndrome or Chronic myelomonocytic leukemia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT [Phase 2]
This Phase 2 trial evaluates a treosulfan/fludarabine/low-dose total body irradiation preparative regimen for children with acute myeloid le…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: The Effect of Blood Transfusion on Endothelial Function
The completed trial assesses the effect of blood transfusion on endothelial function in patients with myelodysplastic syndrome and anemia.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 3]
This Phase 3 trial evaluated cytarabine and daunorubicin with or without gemtuzumab ozogamicin in older patients with acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) [Phase 4]
Phase 4 epidemiological study update evaluating MRI-based assessment of iron overload in patients with thalassemia (including NTDT), myelody…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 safety and pharmacokinetics study of SyB C-1101 in patients with myelodysplastic syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 safety and pharmacokinetics study of SyB L-1101 in patients with recurrent/refractory or relapsed myelodysplastic syndrome has compl…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: APG101 in Myelodysplastic Syndrome [Phase 1]
APG101, an investigational therapy, was studied in a Phase 1 trial for myelodysplastic syndrome; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase I trial evaluating a combination of midostaurin and bortezomib with chemotherapy in relapsed/refractory acute myeloid leukemia has c…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: SB1518 for Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
This update reports Phase 2 results for SB1518 in patients with myelodysplastic syndrome (MDS); the trial was terminated and results were po…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 2]
Eltrombopag was investigated in a Phase 2 study of thrombocytopenic patients with myelodysplastic syndromes or acute myeloid leukemia. The r…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients [Phase 1]
Phase 1 trial assessing the safety and tolerability of oral clofarabine in intermediate to high-risk myelodysplastic syndrome; the study sta…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
This completed clinical trial from Beth Israel Medical Center evaluated whether extended platelet parameters can distinguish immune thromboc…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Phase I Study of Sequential Cord Blood Transplants [Phase 1]
Phase I study of sequential cord blood transplants has completed enrollment for conditions including lymphoma, leukemia, multiple myeloma, a…
-
CLINICAL_TRIALS research · 2016-05-11Clinical Trial Update: Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome [Phase 2]
Clinical trial update on lenalidomide for myelodysplastic syndrome after failure of hypomethylating agents; Phase 2 study status.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies [Phase 1]
Phase 1 study evaluating TG02 Citrate in patients with advanced hematologic malignancies has completed, including AML, ALL, blast crisis, MD…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation [Phase 2]
Phase 2 clinical trial evaluating repeat transplantation for relapsed or refractory hematologic malignancies after prior transplant; the stu…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating birinapant in combination with azacitidine for patients with myelodysplastic syndrome.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Phase 1]
A Phase I clinical trial is evaluating an oncofetal antigen multi-peptide immunotherapy in hematologic cancers, including acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial testing belinostat and bortezomib in relapsed or refractory acute leukemias and myelodysplastic syndrome has completed.